In Brief This Week: Abbott, Thermo Fisher Scientific, Danaher, Oncocyte, Biocartis, More
News items for the week of Feb. 20, 2023.
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
Oncocyte Laying off 40 Percent of Staff, Selling DetermaRx Test
The company has entered into a stock purchase agreement to sell 70 percent of its stake in Razor Genomics and has eliminated its COO and CSO positions.
BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
In an announcement late Wednesday, the company said Ronnie Andrews had stepped down, marking the firm's third major executive to depart in recent months.
Earnings Roundup: T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen
The diagnostics firms posted quarterly financial results late this week.
Apr 14, 2022
Oncocyte Prices $35M Stock, Warrant Public Offering
Mar 18, 2021